gelesis100.com

gelesis.com

About Us - Gelesis

http://www.gelesis.com/about-us.php

Gelesis in the News. And a group of leading obesity researchers. Gelesis is led by a strong management team with expertise in business, material sciences and medicine. The scientific advisory board and clinical advisors are key opinion leaders in the obesity field. Gelesis has generated extensive in vitro, in vivo and clinical data supporting the efficacy and safety of Gelesis100. Gelesis Research and Development Team.

gelesis.com

Clinical Trials - Gelesis

http://www.gelesis.com/clinical-trials.php

Gelesis in the News. Gelesis Clinical Data Presentations (Available for Download). FLOW Study (Weight Loss) Data Presented at ENDO 2014 in Chicago, IL. FLOW Study (Glycemic Control) Data Presented at The Obesity Society 2014 in Boston, MA. FLOW Study (Macronutrient Intake) Data Presented at The European Congress on Obesity 2015 in Prague, Czech Republic. Gelesis Investigators Meeting for the GLOW study, January 2014.

gelesis.com

Board of Directors - Gelesis

http://www.gelesis.com/board-directors.php

Gelesis in the News. John LaMattina, PhD. Chairman of the Board. CEO and Founder, Gelesis. Managing Director and Founder, LaunchCapital. Meghan M. FitzGerald, DrPH. EVP Strategy, M&A, and Health Policy, Cardinal Health. Robert Forrester, LL.B. Stephen Muniz, JD. EVP, Legal and Operations, PureTech Health. Raju Kucherlapati, PhD. Paul C. Cabot Professor of Genetics and a Professor of Medicine and at Harvard Medical School.

gelesis.com

Leadership Team - Gelesis

http://www.gelesis.com/leadership-team.php

Gelesis in the News. Yishai Zohar - CEO and Founder. Mr Zohar is the Founder and Chief Executive Officer of Gelesis Inc., a Boston-based biotechnology company developing first-in-class treatments for obesity and glycemic control. Eyal Ron, PhD - CTO. Dr Eyal S. Ron has over 20 years of experience in the development of devices, biomaterials, drugs and drug delivery systems. Hassan Heshmati, MD - CMO. Alessandro Sannino, PhD - Chief Project Scientist.

gelesis.com

Diabetes and Obesity Statistics - Gelesis

http://www.gelesis.com/unmet-needs.php

Gelesis in the News. Unmet Need in Obesity. Obesity is one of the world’s largest health challenges affecting a substantial portion of the global population. Obesity is one of the world’s largest health challenges affecting a substantial portion of the global population. Unmet Need in Diabetes. Type 2 diabetes is the result of a high level of glucose in a person’s bloodstream due to their resistance to insulin, the hormone that regulates blood sugar. Excess weight is linked with developing type 2 diabetes.

gelesis.com

Gelesis in the News

http://www.gelesis.com/newsroom.php

Gelesis in the News. Gelesis in the News. Gelesis in the News. New allies in war on weight: Companies are exploring novel ways to help people shed unwanted pounds. Additional Graphics from Boston Globe Article. Capsule effective in pre-diabetic patients. Smart Pill Found to Help Overweight, Obese Individuals Slim Down. Gelesis100 capsule leads to greater weight loss in overweight, obese individuals. Early Trial Shows New Hydrogel Promising for Weight Loss. Healio - Endrocrine Today. Gelesis featured at T...

gelesis.com

Press Releases - Gelesis

http://www.gelesis.com/press-releases.php

Gelesis in the News. Gelesis in the News. Gelesis Announces Positive Safety Data from First-In-Human Study of Second Product Candidate, Gelesis200. Gelesis Announces First U.S. Patient Enrolled in Pivotal Gelesis100 Weight-Loss Study. Gelesis Closes $31.5 Million Growth Financing. Gelesis Expands Ongoing Weight Loss Study to Serve as U.S. Pivotal Trial, Significantly Accelerating Development Timeline. Gelesis Presents Additional Data at European Congress on Obesity. Gelesis Closes $22M Equity Financing.

gelesis.com

How It Works - Gelesis

http://www.gelesis.com/our-approach.php

Gelesis in the News. Gelesis100 is a first-in-class therapeutic that is designed to treat the physiological symptoms of hunger without surgery, other invasive procedures or systemically absorbed drugs. It is designed to safely cause significant weight loss. Gelesis100 capsules administered with water prior to a meal. Particles released and expand in stomach by absorbing water. Particles mix homogenously with food and designed to enhance satiety due to increased volume and elasticity of stomach contents.

gelesis.com

Clinical Advisors - Gelesis

http://www.gelesis.com/scientific-advisors.php

Gelesis in the News. Caroline Apovian, MD. Dr Caroline Apovian is Professor of Medicine and Pediatrics at Boston University School of Medicine and Director of the Center for Nutrition and Weight Management at Boston Medical Center. Louis J. Aronne, MD, FACP. Louis J. Aronne, MD, FACP is a leading authority on obesity and its treatment. Arne Astrup, MD. Ken Fujioka, MD. Director of the Nutrition and Metabolic Research Center and the Center for Weight Management in La Jolla California at the Scripps Clinic.